These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24220995)

  • 1. Neurological damage in MSUD: the role of oxidative stress.
    Sitta A; Ribas GS; Mescka CP; Barschak AG; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2014 Mar; 34(2):157-65. PubMed ID: 24220995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
    Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
    Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
    Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
    Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
    Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
    Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
    Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
    Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
    Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
    Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
    Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
    Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
    Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
    Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
    Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the
    Tsai HY; Wu SC; Li JC; Chen YM; Chan CC; Chen CH
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32680850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.
    Mescka CP; de Moura Coelho D; Sitta A; Catarino F; Donida B; Rosa AP; Gonzalez EA; Pinheiro CV; Poletto F; Baldo G; Dutra-Filho CS; Vargas CR
    Metab Brain Dis; 2021 Jun; 36(5):1015-1027. PubMed ID: 33620579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dynamic thiol/disulphide homeostasis as a novel indicator of oxidative stress in maple syrup urine disease patients under treatment.
    Zubarioglu T; Kiykim E; Cansever MS; Neselioglu S; Aktuglu-Zeybek C; Erel O
    Metab Brain Dis; 2017 Feb; 32(1):179-184. PubMed ID: 27535382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
    Bridi R; Braun CA; Zorzi GK; Wannmacher CM; Wajner M; Lissi EG; Dutra-Filho CS
    Metab Brain Dis; 2005 Jun; 20(2):155-67. PubMed ID: 15938133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.
    Mescka CP; Guerreiro G; Donida B; Marchetti D; Wayhs CA; Ribas GS; Coitinho AS; Wajner M; Dutra-Filho CS; Vargas CR
    Metab Brain Dis; 2015 Oct; 30(5):1167-74. PubMed ID: 26002427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
    Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
    Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.